Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures
Stopped Discontinuation of molecule development
Conditions
- Adult Soft Tissue Sarcoma
- Non Small Cell Lung Cancer
- Triple Negative Breast Cancer
- Colorectal Cancer
- Biliary Tract Cancer
Interventions
- DRUG: Ezabenlimab + BI907828
Sponsor
Institut Bergonié
Collaborators